Summary
Quest Diagnostics Incorporated (DGX) filed this 8-K on June 1, 2001, to report the completion of its previously announced two-for-one stock split. This split was effected as a 100% stock dividend, with the record date for stockholders being May 16, 2001, and the split becoming effective on May 31, 2001. This action, approved by stockholders on May 8, 2001, involved an increase in the authorized common shares from 100 million to 300 million. Importantly, the company has restated its historical financial data, including per-share figures, to reflect this stock split, ensuring comparability for investors. The filing also includes the amended Restated Certificate of Incorporation and the restated historical financial data as exhibits.
Key Highlights
- 1Quest Diagnostics completed a two-for-one stock split effective May 31, 2001.
- 2The stock split was executed as a 100% stock dividend.
- 3Stockholder approval for the necessary amendment to increase authorized shares was obtained on May 8, 2001.
- 4The number of authorized common shares increased from 100 million to 300 million.
- 5Historical financial data has been restated to reflect the stock split for comparability.
- 6All per-share data (basic and diluted income/loss) has been adjusted retroactively.
- 7The filing includes the amended Restated Certificate of Incorporation and restated historical financial data as exhibits.
Frequently Asked Questions
The primary purpose of this filing is to officially report that Quest Diagnostics Incorporated has completed its two-for-one stock split, which became effective on May 31, 2001.
The stock split was implemented as a 100% stock dividend. This means if you held one share before the split, you now hold two shares. The split was effective for stockholders of record on May 16, 2001.
The company needed to amend its charter to increase the number of authorized common shares from 100 million to 300 million to accommodate the issuance of new shares required for the two-for-one stock split.
The stock split itself does not change the overall value or equity of the company. However, it will reduce the earnings per share (EPS) as the net income is now divided among a larger number of outstanding shares. Quest Diagnostics has restated its historical financial data to ensure that current and past per-share metrics are comparable.